BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32229578)

  • 1. LDB1 Enforces Stability on Direct and Indirect Oncoprotein Partners in Leukemia.
    Layer JH; Christy M; Placek L; Unutmaz D; Guo Y; Davé UP
    Mol Cell Biol; 2020 May; 40(12):. PubMed ID: 32229578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.
    Layer JH; Alford CE; McDonald WH; Davé UP
    Mol Cell Biol; 2016 Feb; 36(3):488-506. PubMed ID: 26598604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
    El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
    Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
    Visvader JE; Mao X; Fujiwara Y; Hahm K; Orkin SH
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13707-12. PubMed ID: 9391090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation.
    Xu Z; Huang S; Chang LS; Agulnick AD; Brandt SJ
    Mol Cell Biol; 2003 Nov; 23(21):7585-99. PubMed ID: 14560005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LMO2 promotes the development of AML through interaction with transcription co-regulator LDB1.
    Lu L; Wang J; Fang F; Guo A; Jiang S; Tao Y; Zhang Y; Li Y; Zhang K; Zhang Z; Zhuo R; Chu X; Li X; Tian Y; Ma L; Sang X; Chen Y; Yu J; Yang Y; Cao H; Gao J; Lu J; Hu S; Pan J; He H
    Cell Death Dis; 2023 Aug; 14(8):518. PubMed ID: 37573405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of a tethered Lmo2(LIM2) /Ldb1(LID) complex.
    Dastmalchi S; Wilkinson-White L; Kwan AH; Gamsjaeger R; Mackay JP; Matthews JM
    Protein Sci; 2012 Nov; 21(11):1768-74. PubMed ID: 22936624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
    Draheim KM; Hermance N; Yang Y; Arous E; Calvo J; Kelliher MA
    Oncogene; 2011 Mar; 30(10):1252-60. PubMed ID: 21057528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hematopoietic Stem and Progenitor Cell Cistrome: GATA Factor-Dependent cis-Regulatory Mechanisms.
    Hewitt KJ; Johnson KD; Gao X; Keles S; Bresnick EH
    Curr Top Dev Biol; 2016; 118():45-76. PubMed ID: 27137654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Lhx2 suppresses proliferation of human T cell acute lymphoblastic leukemia-derived cells, partly by reducing LMO2 protein levels.
    Miyashita K; Kitajima K; Goyama S; Kitamura T; Hara T
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2310-2316. PubMed ID: 29278703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCL assembles a multifactorial complex that determines glycophorin A expression.
    Lahlil R; Lécuyer E; Herblot S; Hoang T
    Mol Cell Biol; 2004 Feb; 24(4):1439-52. PubMed ID: 14749362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ldb1 complexes: the new master regulators of erythroid gene transcription.
    Love PE; Warzecha C; Li L
    Trends Genet; 2014 Jan; 30(1):1-9. PubMed ID: 24290192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidation of the role of LMO2 in human erythroid cells.
    Inoue A; Fujiwara T; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Harigae H
    Exp Hematol; 2013 Dec; 41(12):1062-76.e1. PubMed ID: 24041784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-stranded DNA-binding proteins regulate the abundance of LIM domain and LIM domain-binding proteins.
    Xu Z; Meng X; Cai Y; Liang H; Nagarajan L; Brandt SJ
    Genes Dev; 2007 Apr; 21(8):942-55. PubMed ID: 17437998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hematopoietic regulator TAL1 is required for chromatin looping between the β-globin LCR and human γ-globin genes to activate transcription.
    Yun WJ; Kim YW; Kang Y; Lee J; Dean A; Kim A
    Nucleic Acids Res; 2014 Apr; 42(7):4283-93. PubMed ID: 24470145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple functions of Ldb1 required for beta-globin activation during erythroid differentiation.
    Song SH; Kim A; Ragoczy T; Bender MA; Groudine M; Dean A
    Blood; 2010 Sep; 116(13):2356-64. PubMed ID: 20570862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ldb1 is required for Lmo2 oncogene-induced thymocyte self-renewal and T-cell acute lymphoblastic leukemia.
    Li L; Mitra A; Cui K; Zhao B; Choi S; Lee JY; Stamos DB; El-Khoury D; Warzecha C; Pfeifer K; Hardwick J; Zhao K; Venters B; Davé UP; Love PE
    Blood; 2020 Jun; 135(25):2252-2265. PubMed ID: 32181817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ldb1-nucleated transcription complexes function as primary mediators of global erythroid gene activation.
    Li L; Freudenberg J; Cui K; Dale R; Song SH; Dean A; Zhao K; Jothi R; Love PE
    Blood; 2013 May; 121(22):4575-85. PubMed ID: 23610375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Ldb1/NLI complexes orchestrate γ-globin repression and reactivation through ETO2 in human adult erythroid cells.
    Kiefer CM; Lee J; Hou C; Dale RK; Lee YT; Meier ER; Miller JL; Dean A
    Blood; 2011 Dec; 118(23):6200-8. PubMed ID: 22010104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.